Delivery Order SPE2DB22D2009-SPE2DB25FL9EY

Award Date 5/13/25
Potential Completion Date 5/14/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,866.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Wegovy 0.5 mg/0.5 ml pens, a medication used for the treatment of obesity. The contract is a delivery order with a firm fixed price, and has an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 1 mg/0.5 ml pens, a medication used to treat obesity. The award has a ceiling value of $2,975.70 and is a firm fixed-price delivery order contract with an ultimate completion date of April 24, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 1 mg/0.5 ml pens, a medication used to treat obesity. The contract has a ceiling value of $2,555.41 and a completion date of April 24, 2025. This award is not set-aside and is a firm fixed-price delivery order contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 0.5 mg/0.5 ml pens, a medication used to treat obesity. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $10,541.65 and a performance period through May 1, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp...
This federal contract award, valued at $4,089.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Wegovy 0.5 mg/0.5 ml pens, a medication used for the treatment of obesity. The contract is a Firm Fixed Price Delivery Order that runs through February 28, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 2.4 mg/0.75 ml pens, a medication used in the treatment of obesity. The contract has a ceiling value of $3,842.83 and a completion date of December 19, 2023. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition....
This federal contract award, valued at $6,890.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 2.4 mg/0.75 ml pens, a medication used for weight management. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 28, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 0.25 mg/0.5 ml pens, a medication used for the treatment of obesity. The contract has a ceiling value of $37,356.40 and is a firm fixed-price delivery order with a completion date of November 15, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,403.14, is for the delivery of Wegovy 0.5 mg/0.5 ml pen 0.5ml, a medication used in the treatment of obesity. The contract is a delivery order with a firm fixed price pricing type, and the ultimate completion date is April 23, 2025. The contract is not set aside for any specific business type....
This federal contract award, valued at $9,711.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract is for the supply of Wegovy 0.25 mg/0.5 ml pen, a medication used for the treatment of obesity. The contract is a firm fixed-price delivery order that is not set aside for any specific business type. It has an ultimate completion date of May 9, 2025. Amerisourcebergen...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL9EY
    Delivery Order

This federal contract award, with a ceiling value of $3,093.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 0.5 mg/0.5 ml pens, a medication used to treat obesity.

The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of May 14, 2025. This award is not associated with a set-aside program, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/12/25, 11:48 AM